Jane Street’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-51,992
Closed -$5M 12331
2026
Q1
$5M Buy
51,992
+26,773
+106% +$2.68M ﹤0.01% 3517
2025
Q4
$2.45M Sell
25,219
-3,765
-13% -$323K ﹤0.01% 4426
2025
Q3
$2.06M Buy
28,984
+19,801
+216% +$1.32M ﹤0.01% 4873
2025
Q2
$549K Buy
9,183
+2,145
+30% +$118K ﹤0.01% 6742
2025
Q1
$369K Buy
+7,038
New +$395K ﹤0.01% 7452
2024
Q4
Sell
-6,243
Closed -$314K 9981
2024
Q3
$314K Sell
6,243
-4,782
-43% -$221K ﹤0.01% 7949
2024
Q2
$484K Buy
+11,025
New +$469K ﹤0.01% 7066
2022
Q2
Sell
-7,483
Closed -$336K 10211
2022
Q1
$336K Buy
+7,483
New +$346K ﹤0.01% 8211

Other funds holding IRMD

Jane Street's IRMD Position: Q2 2026 in Review

Jane Street sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 51,992 shares — an estimated $5M sold.

Jane Street first reported a position in IRMD in Q1 2022 and held it in 8 quarters. The position peaked at $5M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Jane Street reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 51,992 iRadimed shares in Q2 2026, an estimated $5M.
  • Jane Street first reported a position in iRadimed in Q1 2022 and held it in 8 quarters.
  • Jane Street's iRadimed position peaked at $5M in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.